Itf Therapeutics
Healthcare Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
575 Virginia Rd Ste 201, Concord, Massac...Phone Number
(866) 483-8479Website
www.itftherapeutics.comRevenue
<$5 MillionIndustry
About Itf Therapeutics
Itf Therapeutics Org Chart
Is Itf Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Itf Therapeutics had a recent Job posting/layoffs
Check out if Itf Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Itf Therapeutics recently announced quarterly report
Check if Itf Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Itf Therapeutics launches new products
Congratulate Masked Content for being promoted to Masked Content at Itf Therapeutics
Itf Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Itf Therapeutics has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Itf Therapeutics is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Itf Therapeutics is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Itf Therapeutics.
Itf Therapeutics Tech Stack
A closer look at the technologies used by Itf Therapeutics
Most Recent Scoops
Itf Therapeutics News & Media
ITF Therapeutics LLC Announces Multiple Data Presentations at 2026 MDA Clinical and Scientific Conference
Presenting ten abstracts including observations on long-term safety, disease progression, and decline in muscle contractile area with givinostat Encore oral presentation also highlights analyses from the givinostat clinical development program on weight-based flexible dosing CONCORD, Mass....New Data Presented on Givinostat for Treatment of Duchenne Muscular Dystrophy at 2025 Neuromuscular Study Group Annual Scientific Meeting
Additional analyses from the givinostat clinical development program review observations on weight-based flexible dosing, characterization of thrombocytopenia, correlations between pharmacodynamic markers and functional outcomes, and respiratory function CONCORD, Mass., Sept. 26, 2025...ITF Therapeutics Announces Publication of Positive Long-Term Data Reinforcing Givinostat Efficacy and Safety as a Treatment for Duchenne Muscular Dystrophy
New data published in Annals of Clinical and Translational Neurology show that long-term treatment with givinostat can significantly delay loss of key mobility functions in patients with Duchenne muscular dystrophy Meaningful clinical benefit was observed across treatment groups,...
Top Healthcare Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Itf Therapeutics
ITF Therapeutics LLC is dedicated to providing new therapeutic options for individuals living with rare diseases. As the U.S. affiliate of Italfarmaco Group, the company combines an entrepreneurial approach with a legacy of impactful results. They focus on community collaboration and offer resources and services to support informed healthcare decis... Read More